Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Add shares to your
quickpicks to
display them here!

Schroders Cap (INOV)

Price 12.50p on 01-03-2024 at 17:30:02
Change 0.20p 1.63%
Buy 13.50p
Sell 12.50p
Buy / Sell INOV Shares
Last Trade: Buy 18,846.00 at 12.50p
Day's Volume: 264,442
Last Close: 12.50p
Open: 12.50p
Day's Range 12.50p - 12.50p
52wk Range: 11.72p - 15.65p
Market Capitalisation: £106m
VWAP: 12.62101p
Shares in Issue: 845m

Recent Trades History Schroders Cap (INOV)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 18,846 12.50p Ordinary
16:36:41 - 01-Mar-24
Sell* 3,886 12.50p Uncrossing Trade
16:35:27 - 01-Mar-24
Sell* 368 12.51p Ordinary
16:12:46 - 01-Mar-24
Sell* 95 12.51p Ordinary
15:57:21 - 01-Mar-24
Sell* 18,000 12.51p Ordinary
15:46:32 - 01-Mar-24
Sell* 56,000 12.60p Ordinary
15:44:13 - 01-Mar-24
Sell* 3,089 12.51p Ordinary
15:42:21 - 01-Mar-24
Sell* 12,165 12.51p Ordinary
14:39:23 - 01-Mar-24
Sell* 10,187 12.55p Ordinary
14:17:04 - 01-Mar-24
Sell* 20,471 12.66p Ordinary
14:13:19 - 01-Mar-24

Share Price History for Schroders Cap

Time period:
Date Open High Low Close Volume

Share News for Schroders Cap

IN BRIEF: Schroders Capital Global receives Carmot sale distribution

13th Feb 2024 11:26

Schroders Capital Global Innovation Trust PLC - London-based investment trust focused on a portfolio of "highly innovative" companies - Receives a USD5.6 million payment from Basel, Switzerland-based pharmaceutical firm, Roche Holding AG, in relation to the sale of its portfolio company Carmot Therapeutics Inc. Carmot is a Berkley, California-based biotechnology company currently focused on developing treatments for obesity and diabetes. In December, Carmot entered into an agreement to be acquired by Roche for a USD2.7 billion purchase price, alongside up to USD400 million in milestone payments. Schroders says that the USD5.6 million distribution represents a 221% fair value uplift relative to the value of its holding in Carmot of GBP1.4 million in September. Read More

Schroders Capital Global Innovation injects USD1.6 million in Neurona

9th Feb 2024 09:50

(Alliance News) - Schroders Capital Global Innovation Trust PLC on Friday said it had made an investment of USD1.6 million in California-based clinical-stage cell therapy company Neurona Therapeutics. Read More

IN BRIEF: Schroders Capital Global Innovation gets sale milestone fee

5th Feb 2024 13:53

Schroders Capital Global Innovation Trust PLC - London-based investment trust with a diversified portfolio of global private and public equity companies - Receives USD5.8 million distribution related to the first milestone of the Kymab sale to Sanofi SA. In April 2021, Schroders Capital Global Innovation completed the sale of its shares in Kymab to Sanofi for initial proceeds of USD87 million. Company says: "At that time, the company explained there was the potential for additional contingent payments of up to USD27 million subject to the achievement of various development and regulatory milestones. This announced payment reflects the first milestone event, with the potential for USD21 million of further contingent payments in the future." Read More

Schroders Capital notes Roche buys portfolio firm for USD2.7 billion

8th Dec 2023 11:22

(Alliance News) - Schroders Capital Global Innovation Trust PLC on Friday noted that its portfolio company Carmot Therapeutics Inc has been acquired by Roche Holding AG. Read More

TRADING UPDATES: Begbies to meet expectations; McBride shines

20th Nov 2023 17:58

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

FTSE 100 Latest

Login to your account

Forgot Password?

Not Registered